Bruce F. Bebo

8.6k total citations · 1 hit paper
61 papers, 3.7k citations indexed

About

Bruce F. Bebo is a scholar working on Immunology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Bruce F. Bebo has authored 61 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 16 papers in Pathology and Forensic Medicine and 10 papers in Rheumatology. Recurrent topics in Bruce F. Bebo's work include T-cell and B-cell Immunology (17 papers), Psoriasis: Treatment and Pathogenesis (16 papers) and Multiple Sclerosis Research Studies (13 papers). Bruce F. Bebo is often cited by papers focused on T-cell and B-cell Immunology (17 papers), Psoriasis: Treatment and Pathogenesis (16 papers) and Multiple Sclerosis Research Studies (13 papers). Bruce F. Bebo collaborates with scholars based in United States, Canada and Slovakia. Bruce F. Bebo's co-authors include Arthur A. Vandenbark, Halina Offner, Abby S. Van Voorhees, Mark Lebwohl, April W. Armstrong, Sylvia Hsu, Neil J. Korman, Clayton W. Schupp, Amber L. Fyfe‐Johnson and Jeanette C. Schuster and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Immunology.

In The Last Decade

Bruce F. Bebo

60 papers receiving 3.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis

2021 181 citations Amber Salter, Robert J. Fox et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruce F. Bebo United States	31	2.1k	935	631	485	444	61	3.7k
Andrew L. Croxford Switzerland	24	2.6k 1.2×	554 0.6×	199 0.3×	538 1.1×	244 0.5×	31	3.7k
Stephen J. Lalor Ireland	17	2.3k 1.1×	565 0.6×	245 0.4×	751 1.5×	216 0.5×	22	3.4k
Michael P. Pender Australia	45	2.3k 1.1×	2.7k 2.9×	165 0.3×	985 2.0×	788 1.8×	154	5.7k
Caroline Pot Switzerland	27	1.7k 0.8×	637 0.7×	137 0.2×	608 1.3×	184 0.4×	74	3.0k
Elisabetta Volpe Italy	27	1.7k 0.8×	334 0.4×	559 0.9×	756 1.6×	219 0.5×	60	3.2k
Katharina Kreymborg Switzerland	9	1.8k 0.9×	655 0.7×	136 0.2×	569 1.2×	140 0.3×	10	3.0k
Raymond Hupperts Netherlands	40	1.9k 0.9×	3.1k 3.4×	95 0.2×	635 1.3×	447 1.0×	124	4.9k
Wendy Gilmore United States	27	1.2k 0.6×	697 0.7×	68 0.1×	457 0.9×	249 0.6×	47	2.8k
Gopal Murugaiyan United States	30	2.0k 0.9×	350 0.4×	100 0.2×	1.1k 2.4×	220 0.5×	44	4.0k
Marjan A. Versnel Netherlands	38	1.3k 0.6×	272 0.3×	103 0.2×	860 1.8×	689 1.6×	116	4.4k

Countries citing papers authored by Bruce F. Bebo

Since Specialization

Citations

This map shows the geographic impact of Bruce F. Bebo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce F. Bebo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce F. Bebo more than expected).

Fields of papers citing papers by Bruce F. Bebo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce F. Bebo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce F. Bebo. The network helps show where Bruce F. Bebo may publish in the future.

Co-authorship network of co-authors of Bruce F. Bebo

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce F. Bebo. A scholar is included among the top collaborators of Bruce F. Bebo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce F. Bebo. Bruce F. Bebo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dobson, Ruth, et al.. (2025). Toward a global research agenda for preventing multiple sclerosis. Multiple Sclerosis Journal. 32(2). 151–162.

Bebo, Bruce F., Emma Gray, Anne Helme, et al.. (2024). The first global landscape analysis of multiple sclerosis research funding. Multiple Sclerosis Journal. 30(10). 1363–1369. 3 indexed citations

Bebo, Bruce F., Mark Allegretta, Douglas Landsman, et al.. (2022). Pathways to cures for multiple sclerosis: A research roadmap. Multiple Sclerosis Journal. 28(3). 331–345. 16 indexed citations

Newsome, Scott D., Anne H. Cross, Robert J. Fox, et al.. (2021). COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America. Neurology Neuroimmunology & Neuroinflammation. 8(5). 12 indexed citations

Salter, Amber, June Halper, Bruce F. Bebo, et al.. (2020). Covims registry: clinical characterization of SARS-COV-2 infected multiple sclerosis patients in north america. Multiple Sclerosis Journal. 26. 97–97. 3 indexed citations

Helmick, Charles G., et al.. (2013). Psoriasis and Psoriatic Arthritis. American Journal of Preventive Medicine. 44(4). 424–426. 13 indexed citations

Voorhees, Abby S. Van, Sylvia Hsu, Neil J. Korman, et al.. (2011). Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology. 67(3). 459–477. 77 indexed citations

Wan, Joy, Katrina Abuabara, Andrea B. Troxel, et al.. (2011). Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients. Journal of the American Academy of Dermatology. 66(3). 376–386. 26 indexed citations

Rosenbach, Misha, Sylvia Hsu, Neil J. Korman, et al.. (2009). Treatment of erythrodermic psoriasis: From the medical board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology. 62(4). 655–662. 115 indexed citations

10.

Voorhees, Abby S. Van, Mark Lebwohl, Neil J. Korman, et al.. (2009). Treatment of severe scalp psoriasis: From the Medical Board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology. 60(6). 962–971. 79 indexed citations

11.

Ito, Atsushi, Bruce F. Bebo, Agata Matejuk, et al.. (2001). Estrogen Treatment Down-Regulates TNF-α Production and Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Cytokine Knockout Mice. The Journal of Immunology. 167(1). 542–552. 221 indexed citations

12.

Bebo, Bruce F., et al.. (2001). Low-Dose Estrogen Therapy Ameliorates Experimental Autoimmune Encephalomyelitis in Two Different Inbred Mouse Strains. The Journal of Immunology. 166(3). 2080–2089. 286 indexed citations

13.

Burrows, Gregory G., et al.. (2000). Regulation of Encephalitogenic T Cells with Recombinant TCR Ligands. The Journal of Immunology. 164(12). 6366–6371. 36 indexed citations

14.

Bebo, Bruce F., Jeanette C. Schuster, Kirsten Adlard, Arthur A. Vandenbark, & Halina Offner. (2000). INTERLEUKIN 7 IS A POTENT CO-STIMULATOR OF MYELIN SPECIFIC T CELLS THAT ENHANCES THE ADOPTIVE TRANSFER OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS. Cytokine. 12(4). 324–331. 15 indexed citations

15.

Bebo, Bruce F., et al.. (1999). Gender differences in protection from EAE induced by oral tolerance with a peptide analogue of MBP-Ac1-11. Journal of Neuroscience Research. 55(4). 432–440. 36 indexed citations

16.

Bebo, Bruce F., Kirsten Adlard, Ian Robey, et al.. (1998). Novel adjuvants for induction of T-cell and antibody responses to encephalitogenic and regulatory determinants in Lewis rats. Vaccine. 16(1). 99–108. 2 indexed citations

17.

Buenafe, Abigail C., et al.. (1997). A TCR V alpha CDR3-specific motif associated with Lewis rat autoimmune encephalomyelitis and basic protein-specific T cell clones. The Journal of Immunology. 158(11). 5472–5483. 13 indexed citations

18.

Bebo, Bruce F., et al.. (1996). Hypothesis: a possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis. Journal of Neuroscience Research. 45(4). 340–348. 56 indexed citations

19.

Burrows, Gregory G., K. Ariail, B Celnik, et al.. (1996). Variation in H-2Kk peptide motif revealed by sequencing naturally processed peptides from T-cell hybridoma class I molecules. Journal of Neuroscience Research. 45(6). 803–811. 8 indexed citations

20.

Bebo, Bruce F. & D. Scott Linthicum. (1994). Nucleotide sequence of the TNF type I receptor from a mouse endothelioma cell line. Immunogenetics. 39(6). 450–451. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact